Medline Inc. is 1.7x more valuable than RESMED INC by market capitalization ($49.12 B vs $28.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RMD | MDLN |
|---|---|---|
| Market cap | $28.08 B | $49.12 B |
| US-listed rank | #490 | #322 |
| Revenue (latest FY) | $5.15B | $28.43B |
| Net income (latest FY) | $1.40B | $1.16T |
| Net margin | 27.2% | 4069.4% |
| P/E (trailing FY) | 20.0 | 0.0 |
| SEC filings | 2,518 | 103 |
Medline Inc. is 1.7x more valuable than RESMED INC by market capitalization ($49.12 B vs $28.08 B).
In their latest fiscal years, RESMED INC reported $5.15B in revenue while Medline Inc. reported $28.43B.
Full pages: RESMED INC and Medline Inc., or browse the full rankings.